AGGLUTINABILITY OF RED CELLS BY ANTI-I IN PATIENTS WITH THALASSEMIA MAJOR AND OTHER HAEMATOLOGICAL DISORDERS.
D000293:Adolescent; D000740:Anemia; D000741:Anemia, Aplastic; D000743:Anemia, Hemolytic; D000748:Anemia, Macrocytic; D000755:Anemia, Sickle Cell; D000906:Antibodies; D006384:Hemagglutination; D006402:Hematologic Diseases; D006456:Hemoglobinuria; D006457:Hemoglobinuria, Paroxysmal; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008180:Lupus Erythematosus, Systemic; D009101:Multiple Myeloma; D010026:Osteosclerosis; D011086:Polycythemia; D013103:Spherocytosis, Hereditary; D013789:Thalassemia; D013921:Thrombocytopenia; D017086:beta-Thalassemia
D000906:Antibodies
ADOLESCENCE; ANEMIA, APLASTIC; ANEMIA, HEMOLYTIC; ANEMIA, MACROCYTIC; ANEMIA, SICKLE CELL; ANTIBODIES; HEMAGGLUTINATION; HEMOGLOBINURIA, PAROXYSMAL; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE MYELOMA; OSTEOSCLEROSIS; POLYCYTHEMIA; SPHEROCYTOSIS, HEREDITARY; THALASSEMIA; THROMBOPENIA